Skip to main content

Table 3 Estimates of prevalence of central obesity defined by the ATP III and the IDF criteria among iranian adults 25–64 years old

From: Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia

 

High WC by IDFa

High WC by ATPIII

 

National

estimateb

Prevalence

(95% CI)

National

estimateb

Prevalence

(95% CI)

Age

    

   25–34 (n = 1081)

5.0

39.3 (34.2–44.6)

2.7

21.5 (17.5–26.1)

   35–44 (n = 1113)

5.3

58.7 (53.7–63.5)

3.3

37.5 (31.8–43.5)

   45–54 (n = 1069)

4.2

66.7 (61.2–71.8)

2.9

45.5 (39.0–52.2)

   55–64 (n = 970)

2.3

70.0 (64.7–74.7)

1.7

49.5 (42.6–56.5)

Sex

    

   Males (n = 2121)

5.5

34.4 (31.3–37.5)

2.2

13.9 (11.9–16.0)

   Females (n = 2112)

1.1

73.4 (69.5–77.0)

8.4

54.4 (50.0–58.8)

Residential area

    

   Urban (n = 2853)

12.6

56.0 (52.5–59.5)

8.0

35.5 (32.0–39.1)

   Rural (n = 1380)

4.2

47.5 (40.7–54.4)

2.7

29.8 (23.8–36.5)

Total national estimate

(n = 4233)

16.8

53.6 (50.4–56.8)

10.6

33.8 (30.8–37.1)

  1. WC: waist circumference, CI: confidence interval
  2. a ATP III: Third Adult Treatment Panel; IDF: International Diabetes Federation
  3. b Rounded to the nearest million
  4. Estimates are weighted for age, sex, and residential area on the basis of the population of Iran in 2006